BUGDF (Bumrungrad Hospital PCL) EBIT: $287.1 Mil (TTM As of Dec. 2025)


BUGDF Bumrungrad Hospital PCL BUGDF
100 GF Score
Price $4.75
GF Value $5.86
! 1 Warning Sign
View Full Analysis

What is Bumrungrad Hospital PCL EBIT?

Bumrungrad Hospital PCL BUGDF 100 EBIT is $287.1 Mil as of Dec. 2025. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.86. The stock has 1 warning sign investors should review.

Bumrungrad Hospital PCL's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was $73.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $287.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bumrungrad Hospital PCL's annualized ROC % for the quarter that ended in Dec. 2025 was 40.56%. Bumrungrad Hospital PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 65.80%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bumrungrad Hospital PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 7.16%.


Bumrungrad Hospital PCL  (OTCPK:BUGDF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bumrungrad Hospital PCL's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=287.744 * ( 1 - 18.3% )/( (567.875 + 591.247)/ 2 )
=235.086848/579.561
=40.56 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1064.813 - 103.977 - ( 392.961 - max(0, 110.935 - 523.711+392.961))
=567.875

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1154.664 - 121.661 - ( 441.756 - max(0, 129.387 - 594.818+441.756))
=591.247

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Bumrungrad Hospital PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=293.816/( ( (417.383 + max(19.405, 0)) + (432.556 + max(23.692, 0)) )/ 2 )
=293.816/( ( 436.788 + 456.248 )/ 2 )
=293.816/446.518
=65.80 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(113.344 + 9.412 + 6.894) - (103.977 + 0 + 6.268)
=19.405

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(135.195 + 11.755 + 5.4059999999999) - (121.661 + 0 + 7.003)
=23.692

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bumrungrad Hospital PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=287.098/4010.460
=7.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bumrungrad Hospital PCL EBIT Related Terms


Bumrungrad Hospital PCL EBIT Historical Data

* Premium members only.

The historical data trend for Bumrungrad Hospital PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bumrungrad Hospital PCL EBIT Chart

Bumrungrad Hospital PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.95 174.08 246.99 276.61 294.78

Bumrungrad Hospital PCL Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.16 63.54 71.53 78.58 73.45

BUGDF vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bumrungrad Hospital PCL EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bumrungrad Hospital PCL's EV-to-EBIT falls into.


BUGDF
100GF Score
Bumrungrad Hospital PCL BUGDF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bumrungrad Hospital PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $287.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $287.1 Mil mean?
Bumrungrad Hospital PCL (BUGDF) has a EBIT of $287.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bumrungrad Hospital PCL.
Is Bumrungrad Hospital PCL's EBIT too high?
Bumrungrad Hospital PCL's current EBIT is $287.1 Mil. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's EBIT compare to HCA and THC?
Bumrungrad Hospital PCL's EBIT of $287.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Bumrungrad Hospital PCL. Bumrungrad Hospital PCL's current EBIT is $287.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current EBIT of $287.1 Mil. The stock's GF Value™ is $5.86, compared to a current price of $4.75 — trading 18.9% below its estimated fair value. The current EBIT is $287.1 Mil. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current EBIT is $287.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued. The current stock price of $4.75 is trading 18.9% below its estimated GF Value™ of $5.86.

Key valuation signals for BUGDF:

  • EBIT: $287.1 Mil
  • GF Value™: $5.86 vs. price of $4.75 (18.9% below fair value)
  • GF Score™: 100/100 with 1 warning sign

No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bumrungrad Hospital PCL Business Description

Other Exchanges BH:ThailandBZ7A:Germany
Address 33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score

Get the complete analysis for BUGDF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.75
Price
$5.86
GF Value